Clinical Trial Update: Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating decitabine with or without bortezomib in older adults with acute myeloid leukemia; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
• Therapy-related Acute Myeloid Leukemia

Drugs mentioned

• Bortezomib (bortezomib)
• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2016-10-24